With less than a week to go before the 9th China International Import Expo opens in Shanghai, nearly 200 companies and institutions that have participated in all nine editions of the event are set to make their appearance once again.
They have come before, and they want to come back again. What is the magnetic appeal of the CIIE? New products are launched every year, and every year they become hits. Each year, LEGO Group, a "perfect attendance" exhibitor, holds a "global debut" of new products at the CIIE, many of which are product sets inspired by Chinese culture. "For example, the Chinese New Year-themed series that had its global premiere at the CIIE in past years was developed specifically for China but sold globally. We believe this not only makes a meaningful contribution to spreading Chinese culture to the world, but also helps us develop our brand while connecting with local Chinese culture," said Ma Shiming, General Manager of LEGO Group China.
"For us, China is not just a consumer market," Ma Shiming said. Through the window of the CIIE, the company has deeply felt that the Chinese market is becoming a "weather vane" for global consumption, and that with high-quality intellectual property protection and an internationalized, law-based business environment, it is helping multinational companies strengthen their confidence in investing in China. "The CIIE platform drives the efficient transformation of 'exhibits into goods, and goods into hit products,' and we feel this firsthand."
Xu Daren, President of Amorepacific China, another "perfect attendance" exhibitor, said that at this year's CIIE, Amorepacific will bring four globally debuted products, presenting many cutting-edge innovations to Chinese consumers first, further demonstrating the group's high regard for the CIIE as a global new product launch platform and for the Chinese market, and showing through concrete actions its firm determination and confidence to grow together with the local market.
CIIE "perfect attendance" exhibitors are coming with Chinese innovation, and also bringing "new friends." Sheng Wenhao, CEO of Theland Asia Pacific, who has already secured participation for ten consecutive years, said that since the 6th CIIE, Theland has brought more New Zealand companies to exhibit. Many companies such as GRIN and Pacific Alpacas have moved from initially "going overseas as a group" to gaining a firm foothold in the Chinese market, and now exhibit independently at the CIIE. "The platform effect and spillover effect of the CIIE continue to show, and this year we will also join forces with New Zealand Trade and Enterprise to bring 33 companies to exhibit at once."
"As an important platform connecting China and the world, the CIIE creates broad opportunities for global medical technology innovation exchange and cooperation," said Geoff Martha, Chairman and CEO of Medtronic. The CIIE has witnessed Medtronic's continuous progression from a global innovation "introducer" to a "implementer," and then to a "co-builder" of the local innovation ecosystem. Currently, the third phase of the Medtronic China Fund is actively being prepared for launch. Previously, the first two phases of the fund successfully invested in more than 10 Chinese local medical technology innovation companies, covering fields such as surgical robots, neuromodulation, and otolaryngology. "We hope to build a 'two-way bridge,' further continuing to lay out around high-end medical device innovation and key links in the industrial chain, strengthening two-way connections with Medtronic's global business, and supporting the global development of Chinese innovation," Geoff Martha said.
Doug Langa, Global President and CEO of Novo Nordisk, said that this year, Novo Nordisk will hold the global premiere at the CIIE of NovoGel for the treatment of type 2 diabetes. As the latest achievement of the "China Synergy" project, this drug has a Chinese expert serving as the principal investigator of the global Phase 3 clinical study. "The CIIE has become an important platform for us to deepen our presence in China. This year is our ninth consecutive year of participation, and many drugs that had their first exhibition at the CIIE have since been launched in China one after another," Doug Langa said.
Comments